Thornback et al., 1981 - Google Patents
Technetium-99m-Ethylenediamine: A new cationic complex of technetiumThornback et al., 1981
- Document ID
- 1715145236568071237
- Author
- Thornback J
- Theobald A
- Publication year
- Publication venue
- The International Journal of Applied Radiation and Isotopes
External Links
Snippet
Reaction of 99m Tc-pertechnetate with 1, 2-diaminoethane) in the presence of Sn (II) appears to give a single cationic species. At pH 9–10 the complex is stable for greater than 20 h and for greater than 1 h at pH 4–11. Biodistribution studies show that the complex is …
- 125000002091 cationic group 0 title abstract description 5
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/0474—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0476—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/0493—Steroids, e.g. cholesterol, testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Russell et al. | Quality control of Tc-99m DTPA for measurement of glomerular filtration: concise communication | |
| Blower et al. | Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies | |
| US4272503A (en) | Reductant composition for technetium-99m and method for making technetium-99m labelled ligands | |
| Halpern et al. | 99mTc-penicillamine-acetazolamide complex, a new renal scanning agent | |
| CA1215372A (en) | Radioactive chelate complexes containing pyridine-n-oxides | |
| US6506363B1 (en) | Radioiodinated sulfonated phenols and process therefore | |
| Baldas et al. | Effect of the Tc-nitrido group on the behaviour of 99mTc-radiopharmaceuticals | |
| Thornback et al. | Technetium-99m-Ethylenediamine: A new cationic complex of technetium | |
| Vanlić-Razumenić et al. | Studies of chemical and biological properties of 99m Tc-DMS (dimercaptosuccinic acid)—Renal imaging agent | |
| GB2128191A (en) | Radio-labelled quaternary compounds and their diagnostic use | |
| Yano et al. | Cyclotron-produced Zn-62: its possible use in prostate and pancreas scanning as a Zn-62 amino acid chelate | |
| Vanlić-Razumenić et al. | Interaction of 99mTc-radiopharmaceuticals with transport proteins in human blood | |
| Baldas et al. | Preparation, HPLC studies and biological behaviour of 99mTc-and 99mTcN-radiopharmaceuticals based on quinoline type ligands | |
| Anghileri et al. | The 99mTc labeling of erythrocytes | |
| Agha et al. | Comparative labelling and biokinetic studies of 99mTc-EDTA (Sn) and 99mTc-DTPA (Sn) | |
| Hnatowich et al. | The importance of pH and citrate concentration on the in vitro and in vivo behavior of radiogallium | |
| US3749913A (en) | Renal scanning composition and method using technetium 99m | |
| Jansholt et al. | Catabolism and protein binding of Tc-99m pyridoxylideneglutamate | |
| Thakur et al. | Preparation and evaluation of [99mTc] DEPE as a cardiac perfusion agent | |
| Hinkle et al. | Kit preparation of radioiodinated o‐iodohippuran | |
| Vanlić-Razumenić et al. | Preparation of technetium-99-DMS renal complex in solution and its chemical and biological characterization | |
| Baker et al. | Technetium-99m complexes of EDTA analogs: Studies of the radiochemistry and biodistribution | |
| Kroesbergen et al. | 99mTc bone scanning agents—V. Influence of experimental conditions on the labeling efficiency and gel chromatography of 99mTc (Sn) HMDP | |
| Dekker et al. | Gel-chromatographic analysis of 99mTc-labeled human serum albumin prepared with Sn (II) as the reductant | |
| Tanaka et al. | A new radiopharmaceutical: 99m Tc DMP for renal scanning |